• SAP Pushing Hana, Cloud

    Bio-IT World Roundup | SAP is continuing to press forward with its Hana in-memory computing platform and Enterprise Cloud hosting service, including several life sciences deployments.

    Jun 5, 2014

  • DREAM Project Crowdsources Cell Line Sensitivity

    Colorado Cancer Blog | The DREAM Project published the results of their cancer cell line drug sensitivity challenge in the June 1 issue of Nature Biotechnology.

    Jun 5, 2014

  • An Online Community for the World's Whole Genome Owners

    Bio-IT World | With the Empowered Genome Community, QIAGEN hopes to connect researchers to whole genome donors for massive genetic health studies, using the popular Ingenuity Variant Analysis platform as a gateway.

    Jun 4, 2014

  • Pathway Genomics to Donate BRCATrue Tests to Women in Need

    Clinical Informatics News | Pathway Genomics has launched its BRCATrue test for BRCA 1 and BRCA 2 and its BRCA One for One program, hoping to offer the industry’s best BRCA genetic test and make it accessible to a wide range of women.

    Jun 3, 2014

  • Sage Bionetworks and the Thriving Ecosystem of Challenge-Based Discovery

    Bio-IT World | Under the leadership of Stephen Friend, Sage Bionetworks is partnering with the DREAM initiative to foster a growing web of scientific challenges, intended to spur progress on fundamental problems by merging efforts and offering powerful incentives.

    Jun 2, 2014

  • Roche Back in Sequencing Game with $350M Genia Acquisition

    Bio-IT World | Roche acquired Genia Technologies today, in an acquisition intended to strengthen Roche's NGS pipeline, and offer upgrade and migration path for 454 technology.

    Jun 2, 2014

  • Appistry Launches Cloud Dx Platform, PGDx Signs On

    Bio-IT World News Brief | On Friday, Appistry announced its new CloudDx genomics testing service and an agreement with Personal Genome Diagnostics (PGDx) to include in the service PGDx’s CancerSelect panel.

    Jun 1, 2014

  • Policy Group Probes Regulatory Gaps in Synthetic Biology

    Bio-IT World | This week, a policy group including representatives from the J. Craig Venter Institute released a report questioning whether current U.S. regulatory structures are sufficient to address safety and environmental concerns raised by synthetic biology.

    May 30, 2014

  • Informatics Chiefs Take on Cancer

    CIO | Nonprofit CIOs are joining forces against cancer, with informatics heads from the the Leukemia Lymphoma Society, American Cancer Society, and St. Jude meeting annually to discuss everything from their mobile strategy to their vision for the cloud.

    May 30, 2014

  • Genome Analysis in the Cloud and for the Masses

    Bio-IT World | 2014 Best Practices Winner | When the Human Genome Sequence Center (HGSC) at Baylor College of Medicine took on the sequencing and analysis of genomic data from 14,000 individuals, they knew they had a problem of scale. The solution for getting the data analyzed and out to 300 collaborators worldwide won the team and their partners at DNAnexus a 2014 Bio-IT World Best Practices Award for IT Infrastructure and High Performance Computing.

    May 30, 2014

  • China Introduces Its Own Sequencer

    ChemistryWorld | The Beijing Institute of Genomics (BIG, not to be confused with BGI) and a Chinese partner company have launched a sequencing machine capable of longer read lengths than Illumina, 1/3 cheaper to manufacture, and 1/5 cheaper to operate.

    May 29, 2014

  • NextGxDx Doubles Office Space, Grows Genetic Testing Business

    Nashville Business Journal | NextGxDx is doubling its office space, after raising $2.9 million earlier this year. The Nashville, Tenn.-based company intends to serve as a one-stop-shop for doctors and hospitals to order genetic tests for their patients.

    May 29, 2014

  • Twist Bioscience Takes in Funding Round for DNA Synthesizer

    Xconomy | Twist Bioscience yesterday announced a $26 million Series B funding round, as well as a $5 million DARPA contract, to continue development of a high-throughput DNA synthesis device.

    May 28, 2014

  • Quantapore Receives $35m Investment Toward New Sequencer

    San Francisco Business Times | An ex-Ion Torrent scientist has a $35 million investment to prove his new sequencer is faster and cheaper than anything else.

    May 22, 2014

  • Advances in Genetic Engineering at the 2014 American Society for Microbiology Meeting

    Bio-IT World | Presenters at the annual meeting of the American Society for Microbiology showed off new applications for the CRISPR system of gene editing, and projects that have re-coded bacterial genomes on a massive scale.

    May 22, 2014

  • GenePeeks Launches Sperm Donor Matching Service

    Bio-IT World News Brief | GenePeeks has opened its in silico nursery, formally launching the Matchright screening service for families who are planning to use a sperm donor to conceive.

    May 22, 2014

  • N-of-One Signs Agreement with Mayo Clinic

    Bio-IT World News Brief | Mayo Clinic and N-of-One, have signed an agreement under which N-of-One will provide Mayo Clinic with clinical interpretation information to aid in highly complex molecular diagnostics.

    May 21, 2014

  • QIAGEN Adds HGMD and Other BIOBASE Offerings, Plans Ingenuity Clinical

    Bio-IT World News Brief | QIAGEN is adding content from BIOBASE including HGMD, the human gene mutation database, to its bioinformatics offerings. HGMD and other BIOBASE solutions will provide the foundation for Ingenuity Clinical, QIAGEN's forthcoming clinical NGS decision-support solution.

    May 21, 2014

  • A European Look at the Changing Landscape of Prenatal Testing

    Bio-IT World | At the Prenatal Molecular Diagnostics Europe conference last week in Lisbon conversations ranged from the current landscape in prenatal diagnostics to the future vision of the technology and the regulatory environment that will enable it.

    May 21, 2014

  • At AstraZeneca, Occasion for Introspection

    Bio-IT World | On Friday, a frank assessment of AstraZeneca's R&D practices appeared in Nature Reviews Drug Discovery, just as Pfizer's repeated takeover bids have increased scrutiny of AstraZeneca's drug development pipeline.

    May 19, 2014